ADMA Biologics, Inc.
ADMA
$19.64
-$1.67-7.84%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 103.15M | 86.71M | 88.24M | 45.33M | 51.35M |
| Total Receivables | 50.00M | 50.14M | 30.11M | 49.62M | 27.42M |
| Inventory | 170.24M | 171.80M | 179.81M | 177.73M | 172.91M |
| Prepaid Expenses | 8.03M | 9.55M | 5.52M | 3.74M | 5.33M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 331.41M | 318.19M | 303.69M | 276.42M | 257.01M |
|
|
|||||
| Total Current Assets | 331.41M | 318.19M | 303.69M | 276.42M | 257.01M |
| Net Property, Plant & Equipment | 63.34M | 62.59M | 63.48M | 64.71M | 63.47M |
| Long-term Investments | 3.53M | 3.53M | 3.53M | 3.53M | 3.53M |
| Goodwill | 3.53M | 3.53M | 3.53M | 3.53M | 3.53M |
| Total Other Intangibles | 460.00K | 485.00K | 479.00K | 321.00K | 499.00K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 89.94M | 5.82M | 5.22M | 5.89M | 4.67M |
| Total Assets | 488.68M | 390.62M | 376.40M | 350.88M | 329.18M |
|
|
|||||
| Total Accounts Payable | 20.22M | 16.02M | 14.18M | 17.19M | 15.66M |
| Total Accrued Expenses | 28.63M | 24.22M | 22.60M | 31.31M | 30.55M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.22M | 1.19M | 1.14M | 1.09M | 1.05M |
| Total Finance Division Other Current Liabilities | 5.48M | 3.46M | 6.26M | 3.50M | 2.55M |
| Total Other Current Liabilities | 5.48M | 3.46M | 6.26M | 3.50M | 2.55M |
| Total Current Liabilities | 55.54M | 44.89M | 44.18M | 53.09M | 49.81M |
|
|
|||||
| Total Current Liabilities | 55.54M | 44.89M | 44.18M | 53.09M | 49.81M |
| Long-Term Debt | 72.34M | 101.33M | 131.07M | 130.85M | 130.59M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 8.56M | 8.87M | 9.18M | 9.49M | 9.78M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 3.22M | 3.65M | 3.70M | 3.75M | 3.80M |
| Total Liabilities | 139.66M | 158.73M | 188.13M | 197.17M | 193.98M |
|
|
|||||
| Common Stock & APIC | 657.60M | 652.37M | 644.66M | 642.16M | 641.46M |
| Retained Earnings | -308.58M | -420.48M | -456.39M | -488.45M | -506.26M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 349.02M | 231.89M | 188.27M | 153.71M | 135.21M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 349.02M | 231.89M | 188.27M | 153.71M | 135.21M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 349.02M | 231.89M | 188.27M | 153.71M | 135.21M |
|
|
|||||